Strategic National Stockpile

Last updated

Strategic National Stockpile
Agency overview
Formed1999
Preceding agency
  • National Pharmaceutical Stockpile
Agency executive
  • Steven Adams, Deputy Assistant Secretary and Director
Parent agency Administration for Strategic Preparedness and Response
Website Strategic National Stockpile

The Strategic National Stockpile (SNS), originally called the National Pharmaceutical Stockpile (NPS), is the United States' national repository of antibiotics, vaccines, chemical antidotes, antitoxins, and other critical medical supplies. Its website states:

Contents

"The Strategic National Stockpile's role is to supplement state and local supplies during public health emergencies. Many states have products stockpiled, as well. The supplies, medicines, and devices for life-saving care contained in the stockpile can be used as a short-term stopgap buffer when the immediate supply of adequate amounts of these materials may not be immediately available." [1] [2] [3]

In at least 10 government reports published from 2003 to 2015, federal officials predicted that the U.S. would experience a shortage of ventilators and other medical supplies were a large-scale infectious disease outbreak to occur. [4]

Locations

The actual supply of drugs and supplies that make up the SNS are located in 12 [5] secret locations strategically placed throughout the US. The locations appear to look like ordinary commercial warehouses. Inside the warehouses, supplies are stacked on shelves that can measure five stories high. [6] Armed personnel guard the warehouse contents and, according to NPR in 2020, during the COVID-19 global pandemic, "rows of ventilators, which can support people who are having trouble breathing, are kept charged up and ready to roll at a moment's notice." [7]

Composition

The SNS holds a variety of items that would be helpful to the general population in the event of a widespread disease outbreak.[ citation needed ]

12-hour push pack

Each push pack weighs about 50 short tons (100,000 lb; 45 t; 45,000 kg). [6] Its contents include broad-spectrum oral and intravenous antibiotics, emergency medicines, IV fluids and kits, airway equipment, bandages, vaccines, antitoxins, and ventilators. [8] The material deploys by unmarked trucks and airplanes within 12 hours of the receipt of a request by the CDC. The U.S. Marshals Service provides armed security from these federal sites to local destinations. The SNS has adequate vaccines and countermeasures in its stockpile, including 300 million smallpox treatment courses and enough anthrax vaccines to handle a three-city incident. [9]

CHEMPACK

CHEMPACKs contain nerve agent antidotes to help in the event of a nerve agent attack or industrial accident. [10] As of 2015, 1,960 CHEMPACKs were forward-deployed in more than 1,340 locations across each state and territory of the United States. [11]

History

Cold War Era

During the first decade of the Cold War, the United States accumulated a civil defense medical stockpile at 32 storage facilities. The supplies began to degrade in the 1960s, and were disposed of and the stockpile program closed in 1974. [12]

Clinton Administration

In April 1998, President Bill Clinton read the Richard Preston novel The Cobra Event , a fiction book about a mad scientist spreading a virus throughout New York City. As a result, Clinton held a meeting with scientists and cabinet officials to discuss the threat of bioterrorism. He was so impressed that he asked the experts to meet with senior-level aides at the Department of Defense and in the Department of Health and Human Services. [13] At that time, the government had stockpiles of medications for military personnel, but did not have them for civilians. Shortly after, The Washington Post wrote that Clinton surprised many in Washington at how fast he and his National Security Council had moved to change that. By October, Clinton signed into law [14] a new budget of $51 million for pharmaceutical and vaccine stockpiling to be carried out by the CDC. [15]

The US Congress appropriated funds for the CDC to create a pharmaceutical and vaccine stockpile to handle biological and chemical threats from disease that could affect large numbers of the US civilian population, in Public Law 105–277 dated October 21, 1998. [16] The original name was the National Pharmaceutical Stockpile (NPS) program, but additional materials have been added to the stockpile since the original authorization .[ citation needed ]

Bush Administration

The federal government implemented a pandemic blueprint for distribution of Personal Protective Equipment (P.P.E.) from the Strategic National Stockpile, in coordination with public and private efforts. [13]

On March 1, 2003, the NPS was renamed the Strategic National Stockpile (SNS) program with joint management by Department of Homeland Security and Department of Health and Human Services. [17]

In 2005 and in preparation for a predictable pandemic influenza, the Bush administration called for the coordination of domestic production and stockpiling of protective personal equipment. [18] In 2006, the US Congress funded the integration of protective equipment to a Strategic National Stockpile: 52 million surgical masks and 104 million N95 air-filtration masks were acquired and added. [18]

Public Health Emergency lists large-scale deployments from the SNS in response to emergencies. [17]

The SNS successfully deployed 12-hour "push packages" to New York City and Washington, D.C., in response to the September 11 attacks, and managed inventory (MI) to numerous locations in response to the anthrax terrorist attacks of 2001.

Following the landfall of Hurricanes Katrina and Rita on the Gulf coast of Mississippi and Louisiana in September 2005, the CDC deployed SNS assets, technical assistance and response units, plus the newly developed and rapidly deployable "federal medical contingency stations" to state-approved locations near or in the disaster areas. The contingency stations, later renamed Federal Medical Stations (FMS), are caches of equipment and supplies provided by the SNS, set up in local "buildings of opportunity" and staffed by local or federal medical personnel to provide triage, low acuity care, and temporary holding of displaced patients for whom local acute care systems are damaged or destroyed.

Obama administration

Since the original deployment following Hurricane Katrina, FMSs have been deployed to support other major disaster responses including Superstorm Sandy. The FMS program is a collaboration between CDC and the Office of Emergency Management under the HHS Assistant Secretary for Preparedness and Response. In 2014, responding to stakeholder feedback, a 50-bed FMS cache was developed and made available in addition to the original 250-bed FMS. [19]

The SNS released one-quarter of its antiviral drug inventory (Tamiflu and Relenza), personal protective equipment (PPE), and respiratory protection devices, to help every US state respond to the H1N1 Influenza 2009 swine influenza outbreak in the United States. [20]

After the 2009 flu pandemic in which tens of millions of masks were distributed, fiscal constraints imposed by the agency's $600 million annual budget led officials to decide that replenishing a large inventory of N95 face masks was of less priority than stockpiling other equipment and drugs for diseases and disasters. [21]

Trump Administration

During the Trump administration, Trump falsely claimed his administration inherited an ‘empty’ stockpile from the previous administration. [22]

Video produced by HHS in October 2019 about the 20th anniversary of the stockpile.

From 2017 to 2019, the Trump administration failed to replace masks and other supplies used in earlier disasters. In May 2020, in a House subcommittee meeting, whistle-blower Dr. Rick Bright, previous director of Department of Health and Human Services’ Biomedical Advanced Research and Development Authority, explained that the Trump administration had ignored his early warnings to stock up on masks and other supplies to combat the coronavirus. [23]

The Office of the Assistant Secretary for Preparedness and Response (ASPR) of the Department of Health and Human Services has managed the Strategic National Stockpile since October 1, 2018. Prior to that, the stockpile was managed by the Centers for Disease Control and Prevention (CDC).

2020 COVID-19 pandemic

Pallets of unknown materials being moved in March 2020

At the beginning of the COVID-19 pandemic, SNS was involved in providing supplies to the repatriation efforts of State Department employees from China and Japan. It also shipped thousands of N95 masks to the states of Washington, Massachusetts, and New York to respond to their surging infection rates. [24] In March of 2020, SNS director Steven Adams said it had stockpiled 13 million masks and had placed an order for 500 million more by September of 2021. [5] The SNS was criticized for containing over 5 million expired masks. [5]

On March 29, 2020, HHS accepted a donation of 30 million doses of hydroxychloroquine sulfate from Sandoz and one million doses of Resochin (chloroquine phosphate) from Bayer Pharmaceuticals for use in treating hospitalized COVID-19 patients or in clinical trials. The SNS will work with the Federal Emergency Management Agency (FEMA) to deliver the doses to states. [25] The U.S. Food and Drug Administration later withdrew Emergency Use Authorization for these drugs after studies found they had no benefit for treating COVID-19.

On April 1, 2020, Department of Homeland Security officials told reporters that the cache of personal protective equipment stored by the SNS was almost depleted due to the COVID-19 pandemic in the United States. This was later confirmed by President Donald Trump. PPE from the SNS was sent directly to health facilities across the country. [26]

During the COVID-19 pandemic, states criticized the lack of availability of medical supplies from the federal stockpile. At a White House press conference on April 2, 2020, senior advisor Jared Kushner commented "The notion of the federal stockpile was it's supposed to be our stockpile. It's not supposed to be states' stockpiles that they then use." [27] [28] [29] The idea that the stockpile was not a backup for states that run out of supplies was disputed by Governor Laura Kelly of Kansas, [30] among others.

The description of the stockpile, as listed on its website, was changed the day after Kushner's remarks to better align with them, from:

"Strategic National Stockpile is the nation’s largest supply of life-saving pharmaceuticals and medical supplies for use in a public health emergency severe enough to cause local supplies to run out. When state, local, tribal, and territorial responders request federal assistance to support their response efforts, the stockpile ensures that the right medicines and supplies get to those who need them most during an emergency. Organized for scalable response to a variety of public health threats, this repository contains enough supplies to respond to multiple large-scale emergencies simultaneously." [31] [1] [2] [3]

to:

"The Strategic National Stockpile's role is to supplement state and local supplies during public health emergencies. Many states have products stockpiled, as well. The supplies, medicines, and devices for life-saving care contained in the stockpile can be used as a short-term stopgap buffer when the immediate supply of adequate amounts of these materials may not be immediately available." [1] [2] [3]

Washington State announced on April 5, 2020, that it would return more than 400 ventilators it had received from the Stockpile "... to help states facing higher numbers of COVID-19 cases." [32]

On April 8, 2020, HHS contracted with DuPont for 2.25 million Tyvek suits to be delivered to the SNS to be used as PPE for frontline healthcare workers. [33] By April 13, 2020, HHS used the Defense Production Act (DPA) to contract for ventilator production with General Electric, Hill-Rom, Medtronic, ResMed, and Vyaire. Additionally, they contracted with Hamilton and Zoll for ventilator production without using the DPA. The seven contracts were expected to produce 137,431 ventilators by the end of 2020 at a total cost of $1.435 billion. [34]

Biden administration

In January 2022, amidst a surge in cases caused by the more contagious Omicron variant, the CDC updated its guidance [35] to emphasize the greater protection from wearing N95 masks in indoor public spaces. [36] The Biden Administration announced it would distribute 400 million N95 masks from the SNS [37] which started arriving in late January and early February. [38]

2022 monkeypox outbreak

The stockpile was again used during the 2022 monkeypox outbreak. In May 2022, the Centers for Disease Control (CDC) confirmed the United States released some of their Jynneos monkeypox vaccine supply from their Strategic National Stockpile for people who are "high-risk". [39] On May 27, 2022, the CDC specified the indications for the Jynneos vaccine: research laboratory personnel, clinical laboratory personnel performing diagnostic testing for orthopoxviruses, designated response team members, and health care personnel who administer live smallpox Vaccine or care for patients infected with orthopoxviruses. [40]

Criticism

In March of 2021, the New York Times alleged mismanagement involving the Strategic National Stockpile, stating, "In one telling example, The Times found, the government approved a plan in 2015 to buy tens of millions of N95 respirators — lifesaving equipment for medical workers that has been in short supply because of Covid-19 — but the masks repeatedly lost out in the competition for funding over the years leading up to the pandemic, according to five former federal health officials involved in the effort. During the same period, Emergent sold the government nearly $1 billion in anthrax vaccines, financial disclosures show." [41]

Section 403 of the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (H.R. 307; 113th Congress) reauthorized the Strategic National Stockpile for FY2014-FY2018. It required the Secretary of Health and Human Services to:

  1. submit to the appropriate congressional committees, to the extent that the disclosure of such information does not compromise national security, the annual review of the contents of the Stockpile; and
  2. review and revise the contents of the Stockpile to ensure that the potential depletion of countermeasures currently in the Stockpile is identified and appropriately addressed, including through necessary replenishment. [42]

See also

Related Research Articles

<span class="mw-page-title-main">Alex Azar</span> American attorney, businessman, lobbyist and pharmaceutical executive (born 1967)

Alex Michael Azar II is an American attorney, businessman, lobbyist, and former pharmaceutical executive who served as the U.S. Secretary of Health and Human Services from 2018 to 2021. Azar was nominated to his post by President Donald Trump on November 13, 2017, and confirmed by the United States Senate on January 24, 2018. He was also chairman of the White House Coronavirus Task Force from its inception in January 2020 to February 2020, when he was replaced by Vice President Mike Pence.

<span class="mw-page-title-main">Project Bioshield Act</span> US law

The Project Bioshield Act was an act passed by the United States Congress in 2004 calling for $5 billion for purchasing vaccines that would be used in the event of a bioterrorist attack. This was a ten-year program to acquire medical countermeasures to biological, chemical, radiological, and nuclear agents for civilian use. A key element of the Act was to allow stockpiling and distribution of vaccines which had not been tested for safety or efficacy in humans, due to ethical concerns. Efficacy of such agents cannot be directly tested in humans without also exposing humans to the chemical, biological, or radioactive threat being treated, so testing follows the FDA Animal Rule for pivotal animal efficacy.

<span class="mw-page-title-main">Biomedical Advanced Research and Development Authority</span> Government organization in Washington D.C., United States

The Biomedical Advanced Research and Development Authority (BARDA)' is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA) and reports to the Office of the Assistant Secretary for Preparedness and Response (ASPR). The office manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks.

<span class="mw-page-title-main">Administration for Strategic Preparedness and Response</span> US government agency

The Administration for Strategic Preparedness and Response (ASPR) is an operating agency of the U.S. Public Health Service within the Department of Health and Human Services that focuses preventing, preparing for, and responding to the adverse health effects of public health emergencies and disasters. Its functions include preparedness planning and response; building federal emergency medical operational capabilities; countermeasures research, advance development, and procurement; and grants to strengthen the capabilities of hospitals and health care systems in public health emergencies and medical disasters. The office provides federal support, including medical professionals through ASPR’s National Disaster Medical System, to augment state and local capabilities during an emergency or disaster.

<span class="mw-page-title-main">Robert Kadlec</span> American physician and government official

Robert Peter Kadlec is an American physician and career officer in the United States Air Force who served as Assistant Secretary of Health and Human Services from August 2017 until January 2021. He is responsible for the creation of the COVID-19 vaccine development program Operation Warp Speed.

<span class="mw-page-title-main">COVID-19 pandemic in the United States</span>

In the United States, the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in 103,436,829 confirmed cases with 1,177,223 all-time deaths, the most of any country, and the 20th-highest per capita worldwide. The COVID-19 pandemic ranks first on the list of disasters in the United States by death toll; it was the third-leading cause of death in the U.S. in 2020, behind heart disease and cancer. From 2019 to 2020, U.S. life expectancy dropped by 3 years for Hispanic and Latino Americans, 2.9 years for African Americans, and 1.2 years for white Americans. These effects persisted as U.S. deaths due to COVID-19 in 2021 exceeded those in 2020, and life expectancy continued to fall from 2020 to 2021.

<span class="mw-page-title-main">N95 respirator</span> Particulate respirator meeting the N95 standard

An N95 filtering facepiece respirator, commonly abbreviated N95 respirator, is a particulate-filtering facepiece respirator that meets the U.S. National Institute for Occupational Safety and Health (NIOSH) N95 classification of air filtration, meaning that it filters at least 95% of airborne particles that have a mass median aerodynamic diameter of 0.3 micrometers. This standard does not require that the respirator be resistant to oil; another standard, P95, adds that requirement. The N95 type is the most common particulate-filtering facepiece respirator. It is an example of a mechanical filter respirator, which provides protection against particulates but not against gases or vapors. An authentic N95 respirator is marked with the text "NIOSH" or the NIOSH logo, the filter class ("N95"), a "TC" approval number of the form XXX-XXXX, the approval number must be listed on the NIOSH Certified Equipment List (CEL) or the NIOSH Trusted-Source page, and it must have headbands instead of ear loops.

<span class="mw-page-title-main">COVID-19 pandemic in California</span> Ongoing COVID-19 viral pandemic in California, United States

The COVID-19 pandemic in California began earlier than in some other parts of the United States. Ten of the first 20 confirmed COVID-19 infections in the United States were detected in California, and the first infection was confirmed on January 26, 2020. All of the early confirmed cases were persons who had recently travelled to China, as testing was restricted to this group, but there were some other people infected by that point. A state of emergency was declared in the state on March 4, 2020. A mandatory statewide stay-at-home order was issued on March 19, 2020; it was ended on January 25, 2021. On April 6, 2021, the state announced plans to fully reopen the economy by June 15, 2021.

<span class="mw-page-title-main">White House Coronavirus Task Force</span> United States Department of State task force to mitigate COVID-19

The White House Coronavirus Task Force was the United States Department of State task force during the Trump administration, the goal of the Task Force was to coordinate and oversee the administration's efforts to monitor, prevent, contain, and mitigate the spread of coronavirus disease 2019 (COVID-19). Also referred to as the President's Coronavirus Task Force, it was established on January 29, 2020, with Secretary of Health and Human Services Alex Azar as chair. On February 26, 2020, U.S. vice president Mike Pence was named to chair the task force, and Deborah Birx was named the response coordinator.

The following is a timeline of the COVID-19 pandemic in the United States during 2020.

<span class="mw-page-title-main">Shortages related to the COVID-19 pandemic</span> Medical material and other goods shortages caused by the COVID-19 pandemic

Shortages related to the COVID-19 pandemic are pandemic-related disruptions to goods production and distribution, insufficient inventories, and disruptions to workplaces caused by infections and public policy.

Planning and preparing for pandemics has happened in countries and international organizations. The World Health Organization writes recommendations and guidelines, though there is no sustained mechanism to review countries' preparedness for epidemics and their rapid response abilities. National action depends on national governments. In 2005–2006, before the 2009 swine flu pandemic and during the decade following it, the governments in the United States, France, UK, and others managed strategic health equipment stocks, but they often reduced stocks after the 2009 pandemic in order to reduce costs.

<span class="mw-page-title-main">Communication of the Trump administration during the COVID-19 pandemic</span> Aspect of 2020 viral outbreak

The Donald Trump administration communicated in various ways during the COVID-19 pandemic in the United States, including via social media, interviews, and press conferences with the White House Coronavirus Task Force. Opinion polling conducted in mid-April 2020 indicated that less than half of Americans trusted health information provided by Trump and that they were more inclined to trust local government officials, state government officials, the Centers for Disease Control and Prevention (CDC), and National Institute of Allergy and Infectious Diseases director Anthony Fauci.

The National Emergency Stockpile System (NESS) is a federal Government of Canada response to the needs of the health care system in case of an emergency. It is a responsibility of the Public Health Agency of Canada (PHAC).

<span class="mw-page-title-main">Rick Bright</span> American immunologist and whisteblower

Rick Arthur Bright is an American immunologist, vaccine researcher, and public health official. He was the director of the Biomedical Advanced Research and Development Authority (BARDA) from 2016 to 2020. In May 2020, he filed a whistleblower complaint, alleging that the Trump administration ignored his early warnings about the COVID-19 pandemic and illegally retaliated against him by ousting him from his role and demoting him to a position at the National Institutes of Health. On October 6, 2020, Bright resigned from the government. On November 9 he was named a member of President-elect Joe Biden's coronavirus advisory board.

<span class="mw-page-title-main">Face masks during the COVID-19 pandemic in the United States</span> US Health control procedure against COVID-19

The wearing of non-medical face masks in public to lessen the transmission of COVID-19 in the United States was first recommended by the CDC on April 3, 2020, as supplemental to hygiene and appropriate social distancing. Throughout the pandemic, various states, counties, and municipalities have issued health orders requiring the wearing of non-medical face coverings — such as cloth masks — in spaces and businesses accessible to the public, especially when physical distancing is not possible.

<span class="mw-page-title-main">U.S. federal government response to the COVID-19 pandemic</span> Actions by the U.S. federal government regarding the COVID-19 pandemic

The federal government of the United States initially responded to the COVID-19 pandemic in the country with various declarations of emergency, some of which led to travel and entry restrictions and the formation of the White House Coronavirus Task Force. As the pandemic progressed in the U.S. and globally, the U.S. government began issuing recommendations regarding the response by state and local governments, as well as social distancing measures and workplace hazard controls. State governments played a primary role in adopting policies to address the pandemic. Following the closure of most businesses throughout a number of U.S. states, President Donald Trump announced the mobilization of the National Guard in the most affected areas.

<span class="mw-page-title-main">International aid related to the COVID-19 pandemic</span>

Due to its severity, the COVID-19 pandemic has caused countries to send aid, as part of the international responses and management regarding the pandemic. Types of materials aided includes masks, medical supplies, personal protective equipment, money, and test kits. It started with aid to China as the virus spreads primarily there, and then internationally as it spreads globally. The destination of the aid ranges from hospitals, COVID-19 healthcare workers, research on the vaccine, to societies vulnerable. People donating includes the government of said country, notable people, organizations and institutions, charities, as well as regular people.

<span class="mw-page-title-main">Trump administration political interference with science agencies</span> Political interference with science agencies of the Trump administration

During his term as president of the United States (2017–2021), Donald Trump and his administration repeatedly politicized science by pressuring or overriding health and science agencies to change their reporting and recommendations so as to conform to his policies and public comments. This was particularly true with regard to the COVID-19 pandemic in the United States, but also included suppressing research on climate change and weakening or eliminating environmental regulations.

<span class="mw-page-title-main">United States responses to the COVID-19 pandemic</span> Actions by the United States regarding the COVID-19 pandemic

The United States' response to the COVID-19 pandemic with consists of various measures by the medical community; the federal, state, and local governments; the military; and the private sector. The public response has been highly polarized, with partisan divides being observed and a number of concurrent protests and unrest complicating the response.

References

  1. 1 2 3 Weixel, Nathaniel (April 3, 2020). "Trump administration changes definition of national stockpile after Kushner remarks". thehill.com.
  2. 1 2 3 Forgey, Quint (April 3, 2020). "Strategic National Stockpile description altered online after Kushner's remarks". politico.com.
  3. 1 2 3 Blake, Aaron. "The Trump administration just changed its description of the national stockpile to jibe with Jared Kushner's controversial claim". washingtonpost.com.
  4. de Puy Kamp, Majlie (March 27, 2020). "Federal officials repeatedly warned that US hospitals lacked enough ventilators". CNN . Retrieved March 5, 2021.
  5. 1 2 3 "Coronavirus outbreak tests nation's emergency medical stockpile". STAT. March 10, 2020. Archived from the original on June 17, 2020. Retrieved March 18, 2020. With roughly 200 employees, the SNS maintains 12 sites across the country, but keeps their location classified, citing security concerns.
  6. 1 2 Sun, Lena (April 24, 2018). "Inside the secret U.S. stockpile meant to save us all in a bioterror attack". The Washington Post. Retrieved May 5, 2019.
  7. "Why Even A Huge Medical Stockpile Will Be Of Limited Use Against COVID-19". NPR.org. Retrieved March 18, 2020.
  8. "Archived copy" (PDF). Archived from the original (PDF) on September 23, 2020. Retrieved April 3, 2020.{{cite web}}: CS1 maint: archived copy as title (link)
  9. Greenfieldboyce, Nell (June 27, 2016). "Inside A Secret Government Warehouse Prepped For Health Catastrophes". NPR.org. Retrieved June 29, 2017.
  10. "Chempack - Chemm". Archived from the original on September 8, 2021. Retrieved April 3, 2020.
  11. "CDC's CHEMPACK Program—The Stockpile that may protect you from a chemical attack || Blogs | CDC". February 19, 2015.
  12. Coronavirus: Strategic National Stockpile was ready, but not for this
  13. 1 2 Clark, Doug Bock (November 17, 2020). "Inside the Chaotic, Cutthroat Gray Market for N95 Masks". The New York Times . Retrieved November 22, 2020.
  14. "PUBLIC LAW 105–277—OCT. 21, 1998" (PDF). Congress. Retrieved April 4, 2020.
  15. "The Surprising Origins of the U.S. Strategic National Stockpile". Time. Retrieved March 18, 2020.
  16. "PUBLIC LAW 105–277—OCT. 21, 1998" (PDF). Congress. Retrieved April 4, 2020.
  17. 1 2 "Stockpile Responses". phe.gov. United States Department of Health and Human Services. Archived from the original on July 15, 2020. Retrieved July 30, 2020.
  18. 1 2 Manjoo, Farhad (March 25, 2020). "Opinion | How the World's Richest Country Ran Out of a 75-Cent Face Mask". The New York Times. ISSN   0362-4331 . Retrieved March 25, 2020.[ fact or opinion? ]
  19. HHS, ASPR FMS Concept of Operation, 2014
  20. "2009 H1N1 Flu". Archived from the original on April 30, 2009. Retrieved April 27, 2009.
  21. Beth Reinhard and Emma Brown. "Face masks in national stockpile have not been substantially replenished since 2009". The Washington Post. Retrieved November 22, 2020.
  22. D'Angelo Gore Trump Falsely Claims He Inherited ‘Empty’ Stockpile April 3, 2020 FactCheck.org
  23. Stolberg, Sheryl Gay (May 14, 2020). "Lives Were Lost' as Warnings Went Unheeded, Whistle-Blower Tells House". The New York Times . Retrieved November 22, 2020.
  24. "States Need Medical Supplies to Fight Coronavirus. Can the National Stockpile Keep Up With Demand?". Time. Retrieved March 12, 2020.
  25. ASPR Press Office (March 29, 2020). "HHS accepts donations of medicine to Strategic National Stockpile as possible treatments for COVID-19 patients" (Press release). United States Department of Health and Human Services. Archived from the original on July 20, 2020. Retrieved July 30, 2020.
  26. Miroff, Nick. "Protective gear in national stockpile is nearly depleted, DHS officials say — The Washington Post". The Washington Post . Archived from the original on July 8, 2020. Retrieved April 1, 2020.
  27. "Remarks by President Trump, Vice President Pence, and Members of the Coronavirus Task Force in Press Briefing". whitehouse.gov . James S. Brady Press Briefing Room. April 3, 2020. Archived from the original on January 20, 2021. Retrieved July 30, 2020 via National Archives. You also have a situation where, in some states, FEMA allocated ventilators to the states. And you have instances where, in cities, they're running out, but the state still has a stockpile. And the notion of the federal stockpile was it's supposed to be our stockpile; it's not supposed to be state stockpiles that they then use. So we're encouraging the states to make sure that they're assessing the needs, they're getting the data from their local — local situations, and then trying to fill it with the supplies that we've given them.
  28. Wulfsohn, Joseph A. (April 3, 2020). "Trump rips CBS reporter over question on Kushner stockpile remarks: 'You ought to be ashamed of yourself'". Fox News . Archived from the original on June 4, 2020. Retrieved July 30, 2020.
  29. "President Donald Trump and White House Coronavirus Task Force Daily Press Briefing | FULL — 4/2/2020 - YouTube". YouTube .
  30. Ordoñez, Franco (April 3, 2020). "Jared Kushner's Role In Coronavirus Response Draws Scrutiny". NPR . Archived from the original on May 14, 2020. Retrieved July 30, 2020.
  31. "Strategic National Stockpile (April 3 web archive)". U.S. Department Health & Human Services. Archived from the original on April 3, 2020.
  32. "We're in this together – Washington state to send ventilators". governor.wa.gov. Archived from the original on April 8, 2020. Retrieved April 6, 2020.
  33. ASPR Press Office (April 8, 2020). "HHS to Provide Millions of TYVEK Protective Suits for U.S. Healthcare Workers" (Press release). United States Department of Health and Human Services. Archived from the original on June 25, 2020. Retrieved July 30, 2020.
  34. ASPR Press Office (April 13, 2020). "HHS Announces New Ventilator Contracts, Orders Now Totaling Over 130,000 Ventilators" (Press release). United States Department of Health and Human Services. Archived from the original on July 17, 2020. Retrieved July 30, 2020.
  35. Types of Masks and Respirators
  36. Ready for an N95? Here's how to find a high-quality one that fits you well
  37. "Biden administration to distribute 400 million N95 masks to the public for free Politics". CNN . January 19, 2022. Archived from the original on May 23, 2023.
  38. Free N95 masks are arriving at pharmacies and grocery stores. Here's how to get yours
  39. Howard, Jacqueline; Langmaid, Virginia (May 23, 2022). "US in process of releasing monkeypox vaccine from national stockpile for 'high-risk' people, CDC says". CNN. Retrieved May 24, 2022.
  40. Rao, Agam K. (2022). "Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022". MMWR. Morbidity and Mortality Weekly Report. 71 (22): 734–742. doi:10.15585/mmwr.mm7122e1. ISSN   0149-2195. PMC   9169520 . PMID   35653347. S2CID   249142212.
  41. Hamby, Chris; Stolberg, Sheryl Gay (March 6, 2021). "How One Firm Put an 'Extraordinary Burden' on the U.S.'s Troubled Stockpile". The New York Times . Retrieved March 8, 2022.
  42. "H.R. 307". United States Congress. March 13, 2013. Retrieved April 10, 2013.